This inventor holds 1 USPTO granted patent. Top assignee: Biocon Biologics Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Sandhya Hedge: Innovator in Insulin Purification
Introduction
Sandhya Hedge is a prominent inventor based in Karnataka, India. She has made significant contributions to the field of biotechnology, particularly in the purification of insulin analogues. Her innovative work has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.
Latest Patents
Sandhya Hedge holds a patent for a chromatography process for the purification of insulin analogues. This invention relates to a process for purifying non-glycosylated insulin analogues from a mixture that includes both glycosylated and non-glycosylated proteins. The process effectively removes glycosylated proteins through a combination of two reverse-phase high-performance liquid chromatography (RP-HPLC) steps. This advancement is vital for improving the quality and efficacy of insulin treatments.
Career Highlights
Sandhya Hedge is currently associated with Biocon Biologics Limited, a leading biopharmaceutical company in India. Her role at Biocon allows her to work on cutting-edge research and development projects that aim to improve healthcare solutions. With her expertise, she contributes to the company's mission of making biopharmaceuticals accessible to patients worldwide.
Collaborations
Some of her notable coworkers include Ramprabu Nagarajan and Minal Hashim. Their collaborative efforts in research and development have further strengthened the innovative capabilities of Biocon Biologics Limited.
Conclusion
Sandhya Hedge is a remarkable inventor whose work in insulin purification showcases her dedication to advancing biotechnology. Her contributions are paving the way for improved diabetes treatments, making a significant impact in the healthcare industry.